Related Experiment Videos
Opana(®) ER induced thrombotic thrombocytopenic purpura
Nabil Kotbi1, Bernadine Han1, Duncan Cheng1
1Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY, USA.
International Medical Case Reports Journal
|May 22, 2015
Abstract:
We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana, which is a growing concern.